UnitedHealth Group Incorporated (UNH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
UnitedHealth Group Incorporated (UNH) trades at $425.36 with AI Score 77/100 (Grade A). UnitedHealth Group Incorporated is a diversified healthcare company operating in the United States. Market cap: $386.29B, Sector: Healthcare.
Price live · AI analysis from May 10, 2026UNH stock analysis for 2026: Analysts have set a consensus price target of $364.63 for UnitedHealth Group Incorporated, suggesting 14.3% downside from the current price of $425.36. The AI MoonshotScore is 77/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
UNH: 1/2 perspectives are bullish.
How is this calculated? →UnitedHealth Group Incorporated (UNH) Healthcare & Pipeline Overview
UnitedHealth Group, a diversified healthcare leader, provides health benefit plans and services through its UnitedHealthcare and Optum segments. With a $386.29B market cap and a 2.33% dividend yield, UNH navigates the evolving healthcare landscape, focusing on consumer-oriented solutions and integrated pharmacy care, while managing a beta of 0.41.
What Is the Investment Thesis for UNH?
UnitedHealth Group presents a compelling investment thesis driven by its diversified business model and leading market position. The company's four segments—UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx—provide multiple revenue streams and growth opportunities. With a market capitalization of $386.29B and a dividend yield of 2.33%, UNH offers both stability and income potential. Key catalysts include the continued expansion of Optum's care delivery services and the growth of UnitedHealthcare's Medicare and Medicaid plans. However, investors should be aware of potential risks such as regulatory changes and increased competition in the healthcare industry. The company's P/E ratio of 31.1 reflects investor expectations for continued growth, supported by its strong brand and extensive network.
Based on FMP financials and quantitative analysis
UNH Key Highlights
- Market Cap of $386.29B demonstrates UnitedHealth Group's significant presence and valuation in the healthcare sector.
- P/E Ratio of 31.1 indicates investor expectations for future earnings growth relative to its current stock price.
- Profit Margin of 2.7% reflects the company's ability to generate profit from its revenue after accounting for various expenses.
- Gross Margin of 18.8% shows the percentage of revenue remaining after deducting the cost of goods sold, indicating operational efficiency.
- Dividend Yield of 2.33% provides investors with a return on investment through dividend payments, enhancing the stock's attractiveness.
Who Are UNH's Competitors?
UNH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AZN AstraZeneca PLC | $195.15 | +6.14% | $302.65B | 61 |
| NVS Novartis AG | $159.90 | +3.74% | $305.10B | 57 |
| MRK Merck & Co., Inc. | $129.52 | +3.31% | $319.89B | 83 |
| NVO Novo Nordisk A/S | $50.43 | +3.40% | $224.10B | 51 |
| ABT Abbott Laboratories | $95.39 | +3.48% | $166.15B | 70 |
| ALHC Alignment Healthcare, Inc. | $23.80 | -0.87% | $4.92B | 52 |
| GTS Triple-S Management Corporation | $35.99 | +1.04% | 52 | |
| HUM Humana Inc. | $396.75 | -3.09% | $47.63B | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are UNH's Key Strengths?
- Diversified business model with multiple revenue streams.
- Large scale and market share in the health insurance and healthcare services markets.
- Strong brand recognition and customer base.
- Integrated approach combining health plans, pharmacy benefits management, and healthcare services.
What Are UNH's Weaknesses?
- Exposure to regulatory changes and government policies.
- Dependence on relationships with healthcare providers and payers.
- Potential for increased competition in the healthcare industry.
- Profit margin of 2.7% is relatively low compared to some competitors.
What Could Drive UNH Stock Higher?
- Expansion of OptumHealth's care delivery services, driven by the shift towards value-based care.
- Growth in Medicare and Medicaid markets due to the aging population and increasing government spending.
- Potential acquisitions or partnerships to expand capabilities and market reach.
- Leveraging data analytics and technology to improve operational efficiency and care coordination.
- Expansion of pharmacy care services, including specialty pharmacy and medication adherence programs.
What Are the Key Risks for UNH?
- Rich valuation — a P/E of 31.1 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Changes in healthcare regulations and government policies could impact revenue and profitability.
- Increased competition from other healthcare companies could lead to pricing pressure and loss of market share.
- Rising healthcare costs and pressure to reduce premiums could squeeze margins.
- Cybersecurity threats and data breaches could compromise patient data and damage the company's reputation.
- Dependence on relationships with healthcare providers and payers could be affected by contract negotiations and market dynamics.
What Are the Growth Opportunities for UNH?
- Expansion of OptumHealth's Care Delivery Services: OptumHealth is poised for growth through the expansion of its care delivery services, including primary care, specialty care, and virtual care offerings. The market for value-based care is expanding, driven by the shift towards population health management and the need to improve health outcomes while reducing costs. OptumHealth's integrated care model and data analytics capabilities provide a competitive advantage in this market, with potential for significant revenue growth over the next 3-5 years.
- Growth in Medicare and Medicaid Markets: UnitedHealthcare has significant growth opportunities in the Medicare and Medicaid markets, driven by the aging population and increasing government spending on healthcare. The company's experience in managing complex populations and its strong relationships with healthcare providers position it to capture a larger share of these markets. Expansion in these segments could contribute substantially to revenue growth over the next 3-5 years.
- Leveraging Data Analytics and Technology: UnitedHealth Group can leverage its data analytics capabilities and technology infrastructure to improve operational efficiency, enhance care coordination, and develop innovative healthcare solutions. The company's OptumInsight segment provides data analytics and consulting services to healthcare providers and payers, enabling them to make data-driven decisions and improve patient outcomes. Continued investment in data analytics and technology will drive growth and enhance UnitedHealth Group's competitive advantage.
- Strategic Acquisitions and Partnerships: UnitedHealth Group has a history of strategic acquisitions and partnerships that have expanded its capabilities and market reach. The company can continue to pursue acquisitions and partnerships to strengthen its position in key markets, expand its service offerings, and gain access to new technologies. These strategic moves can contribute to long-term growth and enhance shareholder value.
- Expansion of Pharmacy Care Services: OptumRx has opportunities to expand its pharmacy care services, including specialty pharmacy, home delivery, and medication adherence programs. The market for pharmacy care services is growing, driven by increasing prescription drug spending and the need to improve medication adherence. OptumRx's scale and expertise in pharmacy benefits management provide a competitive advantage in this market, with potential for significant revenue growth over the next 3-5 years.
What Opportunities Does UNH Have?
- Expansion in the Medicare and Medicaid markets.
- Growth in value-based care and population health management.
- Leveraging data analytics and technology to improve operational efficiency and care coordination.
- Strategic acquisitions and partnerships to expand capabilities and market reach.
What Threats Does UNH Face?
- Changes in healthcare regulations and government policies.
- Increased competition from other healthcare companies.
- Rising healthcare costs and pressure to reduce premiums.
- Cybersecurity threats and data breaches.
What Are UNH's Competitive Advantages?
- Scale: UnitedHealth Group is one of the largest healthcare companies in the United States, providing economies of scale and negotiating power.
- Diversification: The company's diversified business model, encompassing health plans, pharmacy benefits management, and healthcare services, reduces risk and provides multiple revenue streams.
- Brand Recognition: UnitedHealth Group has a strong brand reputation and a large customer base, providing a competitive advantage in the market.
- Integrated Services: The company's integrated approach, combining health plans, pharmacy benefits management, and healthcare services, allows it to provide comprehensive solutions to its customers.
What Does UNH Do?
UnitedHealth Group Incorporated, established in 1977 and headquartered in Minnetonka, Minnesota, has evolved into a diversified healthcare giant in the United States. The company operates through four distinct segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. UnitedHealthcare provides a wide array of consumer-oriented health benefit plans and services, catering to national employers, public sector entities, mid-sized and small businesses, and individual consumers. These offerings include healthcare coverage, well-being services for individuals aged 50 and older, and specialized programs addressing chronic diseases. The OptumHealth segment delivers access to networks of care provider specialists, health management services, care delivery solutions, consumer engagement platforms, and financial services. This segment serves individuals directly through care delivery systems, as well as employers, payers, and government entities. OptumInsight offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. OptumRx provides comprehensive pharmacy care services and programs, encompassing retail network contracting, home delivery, specialty and compounding pharmacy services, and purchasing and clinical capabilities. UnitedHealth Group's integrated approach and broad service portfolio position it as a key player in the healthcare industry, addressing diverse needs across the healthcare spectrum.
What Products and Services Does UNH Offer?
- Provides consumer-oriented health benefit plans and services.
- Offers healthcare coverage and well-being services to individuals age 50 and older.
- Manages Medicaid plans, children's health insurance, and healthcare programs.
- Provides access to networks of care provider specialists.
- Offers health management services and care delivery.
- Provides pharmacy care services and programs, including retail network contracting and home delivery.
- Offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts.
How Does UNH Make Money?
- Generates revenue through premiums from health insurance plans.
- Provides healthcare services through its OptumHealth segment, generating revenue from care delivery and management.
- Offers pharmacy care services through OptumRx, generating revenue from prescription drug sales and pharmacy benefits management.
- Provides software and information products through OptumInsight, generating revenue from licensing and consulting services.
What Industry Does UNH Operate In?
UnitedHealth Group operates within the dynamic and evolving healthcare industry, which is characterized by increasing demand for healthcare services, technological advancements, and regulatory changes. The industry is experiencing growth driven by an aging population, rising chronic disease prevalence, and expanding access to healthcare coverage. UnitedHealth Group competes with other major players in the health insurance and healthcare services markets. The company's integrated approach, encompassing health plans, pharmacy benefits management, and healthcare services, positions it to capitalize on industry trends and maintain a competitive edge.
Who Are UNH's Key Customers?
- National employers
- Public sector employers
- Mid-sized employers
- Small businesses
- Individuals
- Individuals age 50 and older
- Hospital systems, physicians, health plans, governments, life sciences companies
UnitedHealth Group Incorporated (UNH) Valuation Context
Valued at $386.29B, UNH is classified as a mega-cap stock. Relative to its peer group, UNH's quantitative score of 77/100 is above the peer average of 64/100.
UNH Revenue & Earnings Trend
In Q1 2026, UNH generated $111.72B in top-line revenue, marking a sequential decrease of 1.3%. The company recorded net income of $6.28B, with diluted EPS of $6.90. Quarter-over-quarter revenue has been mixed, typical for a mega-cap company operating in Healthcare. Across the four most recent quarters, UNH averaged $3.31 in diluted EPS.
Company Profile
UnitedHealth Group Incorporated operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Eden Prairie, US. The company is led by CEO Stephen J. Hemsley. UNH has traded publicly since 1984.
ROE 12%Key Financial Metrics
Return on equity for UnitedHealth Group Incorporated stands at 12.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.9%, showing how much profit it generates from its asset base. UNH trades at a trailing price-to-earnings ratio of 31.06, above the Healthcare sector average of ~23x. Its free cash flow yield is 5.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.80 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 3.1%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
UnitedHealth Group Incorporated's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.66 places it in the grey zone, a middle ground that warrants monitoring.
5/8 beatsEarnings Track Record
UnitedHealth Group Incorporated has beaten Wall Street's EPS estimate in 5 of its last 8 reported quarters — more hits than misses. Reported results have landed about 1.3% above estimates on average.
FY2026 estForward Outlook
Wall Street analysts project UnitedHealth Group Incorporated revenue of about $443.73B for fiscal 2026, with EPS near $18.39. The estimate reflects 18 contributing analysts.
Net buyingInsider Activity
Over the past six months, UnitedHealth Group Incorporated insiders filed 15 SEC Form 4 transactions — 0 sales and 15 purchases. On net that is roughly 706 shares acquired (about $0) — insiders putting money in tends to read as conviction.
UNH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Insider buying activity suggests confidence in future performance, reflecting a positive outlook from key stakeholders.
- Recent healthcare policy developments have positioned UnitedHealth favorably, enhancing its market presence and growth potential.
- Community sentiment has been increasingly optimistic, with discussions highlighting the company’s resilience in a changing healthcare landscape.
- Analysts have noted strong fundamentals, including consistent revenue growth and a diversified service portfolio, bolstering investor confidence.
Bear Case
- Concerns over rising healthcare costs have sparked debates among investors, potentially impacting profit margins in the near term.
- Social sentiment has seen some bearish commentary regarding regulatory challenges that could affect operational flexibility.
- Recent market volatility has led to heightened scrutiny of healthcare stocks, with some investors expressing caution about potential downturns.
- Competitive pressures from emerging health tech companies are raising questions about UnitedHealth's market share and long-term sustainability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
From the Earnings Call
“As we have shared over the past 3 quarters, our efforts are focused on management and process improvements that steadily improve margins at Optum Health for 2026 and accelerate into 2027.”
— Patrick Conway
“We continue to expect membership attrition and negative margins in 2026 in light of continuing high trend and insufficient funding with modest margin improvements beginning in 2027.”
— Timothy Noel
UNH Q1 FY2026 earnings call transcript · 2026-04-21
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $111.72B | $6.28B | $6.90 |
| Q4 2025 | $113.22B | $10M | $0.01 |
| Q3 2025 | $113.16B | $2.35B | $2.57 |
| Q2 2025 | $111.62B | $3.41B | $3.74 |
Based on FMP financials and quantitative analysis
UNH Latest News
-
UNH, Humana, CVS Soar, and Wall Street Analysts Take Note
benzinga · Jul 4, 2026
-
10 Health Care Stocks With Whale Alerts In Today’s Session
benzinga · Jul 1, 2026
-
Technical Assessment: Bullish in the Intermediate-Term
Argus Research · Jun 29, 2026
-
If You Invested $100 In UnitedHealth Group Stock 15 Years Ago, You Would Have This Much Today
benzinga · Jun 22, 2026
UNH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for UNH.
Price Targets
Consensus target: $364.63
UNH MoonshotScore
What does this score mean?
The MoonshotScore rates UNH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
UNH, Humana, CVS Soar, and Wall Street Analysts Take Note
10 Health Care Stocks With Whale Alerts In Today’s Session
Technical Assessment: Bullish in the Intermediate-Term
If You Invested $100 In UnitedHealth Group Stock 15 Years Ago, You Would Have This Much Today
Latest UnitedHealth Group Incorporated Analysis
Tech Sector Pulls Back, Nasdaq 100 Dips 1.61% While Dow Gains 1.14%
2 min readXRP Climbs 2.19% on Regulatory Hopes and Consortium News, Ethereum Adds 1.02%
3 min readS&P 500 Retreats 1.2% After Record Highs, IWM Down 2.41%
2 min readXRP Ledger Activity Surges Amid $2 Billion Electricity Tokenization Breakthrough
2 min readAlibaba-Backed DeepRoute.ai Boosts BABA (+3.12%), Bitcoin Nears $80K
2 min readLeadership: Stephen J. Hemsley
CEO
Stephen J. Hemsley has served in various leadership roles at UnitedHealth Group for several years, demonstrating a deep understanding of the healthcare industry. His career includes extensive experience in healthcare management and strategic planning. He has been instrumental in guiding UnitedHealth Group's growth and diversification, overseeing its expansion into new markets and service offerings. Hemsley's leadership is characterized by a focus on innovation, efficiency, and customer satisfaction.
Track Record: Under Stephen J. Hemsley's leadership, UnitedHealth Group has achieved significant milestones, including substantial revenue growth, expansion of its Optum business, and increased market share in key segments. He has overseen strategic acquisitions and partnerships that have strengthened the company's position in the healthcare industry. Hemsley's focus on innovation and efficiency has contributed to improved operational performance and enhanced shareholder value. He manages 400000 employees.
What Investors Ask About UnitedHealth Group Incorporated (UNH) — Healthcare
What does UnitedHealth Group Incorporated do?
UnitedHealth Group Incorporated operates as a diversified healthcare company, offering a range of health benefit plans and services through its four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The company provides health insurance plans to individuals, employers, and government entities. Additionally, it offers pharmacy benefits management, care delivery, and healthcare technology solutions. UnitedHealth Group's integrated approach and broad service portfolio position it as a key player in the healthcare industry, addressing diverse needs across the healthcare spectrum. The company focuses on improving access to care, enhancing the quality of care, and reducing healthcare costs.
What do analysts say about UNH stock?
Analysts generally view UnitedHealth Group favorably, citing its strong market position, diversified business model, and growth opportunities. The consensus rating on UNH stock is typically a 'Buy' or 'Outperform,' reflecting expectations for continued revenue and earnings growth. Key valuation metrics, such as the price-to-earnings ratio and price-to-sales ratio, are often compared to industry peers to assess the stock's relative value. Analysts also consider factors such as regulatory changes, competition, and macroeconomic trends when evaluating UNH stock. However, analyst ratings and price targets are subject to change based on market conditions and company performance.
What are the main risks for UNH?
UnitedHealth Group faces several risks, including regulatory changes, increased competition, and rising healthcare costs. Changes in healthcare regulations and government policies could impact the company's revenue and profitability. Increased competition from other healthcare companies could lead to pricing pressure and loss of market share. Rising healthcare costs and pressure to reduce premiums could squeeze margins. Additionally, cybersecurity threats and data breaches could compromise patient data and damage the company's reputation. The company's dependence on relationships with healthcare providers and payers could be affected by contract negotiations and market dynamics. These risks could negatively impact UnitedHealth Group's financial performance and stock price.
What are the key factors to evaluate for UNH?
UnitedHealth Group Incorporated (UNH) holds an AI score of 77/100 (high). P/E: 31.1x vs the S&P 500's ~20-25x. Analysts target $364.63 (-14%). Not financial advice.
How frequently does UNH data refresh on this page?
UNH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven UNH's recent stock price performance?
UnitedHealth Group Incorporated (UNH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model with multiple revenue streams. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider UNH overvalued or undervalued right now?
UnitedHealth Group Incorporated (UNH) trades at 31.1x earnings. Analysts target $364.63 (-14%) — downside risk seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying UNH?
Before investing in UnitedHealth Group Incorporated (UNH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest available reporting period.